Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP646024.RAfyW70ij3a20gwB0ESxxa0X1AAF1V0FwRdo9kPgbrc_w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP646024.RAfyW70ij3a20gwB0ESxxa0X1AAF1V0FwRdo9kPgbrc_w130_assertion type Assertion NP646024.RAfyW70ij3a20gwB0ESxxa0X1AAF1V0FwRdo9kPgbrc_w130_head.
- NP646024.RAfyW70ij3a20gwB0ESxxa0X1AAF1V0FwRdo9kPgbrc_w130_assertion description "[Thus, our results suggest that targeting ERK-MKP-1 signaling could overcome cisplatin resistance in human ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646024.RAfyW70ij3a20gwB0ESxxa0X1AAF1V0FwRdo9kPgbrc_w130_provenance.
- NP646024.RAfyW70ij3a20gwB0ESxxa0X1AAF1V0FwRdo9kPgbrc_w130_assertion evidence source_evidence_literature NP646024.RAfyW70ij3a20gwB0ESxxa0X1AAF1V0FwRdo9kPgbrc_w130_provenance.
- NP646024.RAfyW70ij3a20gwB0ESxxa0X1AAF1V0FwRdo9kPgbrc_w130_assertion SIO_000772 18089824 NP646024.RAfyW70ij3a20gwB0ESxxa0X1AAF1V0FwRdo9kPgbrc_w130_provenance.
- NP646024.RAfyW70ij3a20gwB0ESxxa0X1AAF1V0FwRdo9kPgbrc_w130_assertion wasDerivedFrom befree-2016 NP646024.RAfyW70ij3a20gwB0ESxxa0X1AAF1V0FwRdo9kPgbrc_w130_provenance.
- NP646024.RAfyW70ij3a20gwB0ESxxa0X1AAF1V0FwRdo9kPgbrc_w130_assertion wasGeneratedBy ECO_0000203 NP646024.RAfyW70ij3a20gwB0ESxxa0X1AAF1V0FwRdo9kPgbrc_w130_provenance.